查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600689

Cystatin C检测法市场：按产品类型、检测法、样品类型、设定、应用和最终用户 - 2025-2030 年全球预测

Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Cystatin C检测法市值为4.2747亿美元，预计到2024年将达到4.5983亿美元，复合年增长率为7.24%，预计到2030年将达到6.9741亿美元。

Cystatin C检测法是一种医学诊断工具，用于测量Cystatin C是一种反映肾功能的蛋白质，可提供比传统肌酸酐检测更准确的评估。该测试的必要性在于它能够提供更快、更准确的有关肾功能下降的信息，这使得它对于慢性肾臟病(CKD) 监测、心血管风险评估和肾病学研究等应用至关重要。最终用途包括医院、诊断实验室和研究机构。慢性肾臟病盛行率的上升、人口老化以及对准确诊断的需求不断增加正在推动市场发展。影响生长的关键因素包括测量技术的进步、肾臟健康意识的提高以及将Cystatin C检测纳入常规健康检查。最新的机会出现在医疗基础设施正在改善的新兴市场以及由于生活方式因素而导致 CKD 发病率较高的地区。此外，整合遗传标记和Cystatin C的组合检测的开发有可能融入个人化医疗的趋势。

主要市场统计
基准年[2023] 4.2747亿美元
预测年份 [2024] 45983万美元
预测年份 [2030] 6.9741亿美元
复合年增长率（%） 7.24%

然而，高成本、新兴市场医疗保健专业人员缺乏意识以及由于非标准化测试方法导致测试结果变化等挑战可能会阻碍市场成长。技术进步等领域需要创新，以降低成本并提高检查速度和准确性。投资新兴市场医疗保健提供者的教育和培训可以使检测的好处更加明确和广泛，从而有可能增加采用率。儘管由于不断的技术创新和监管挑战，市场目前竞争激烈且分散，但透过与生物技术公司合作以及专注于可携式或就地检验解决方案，存在扩展的机会。总体而言，扩大早期诊断和慢性病管理的应用可能会维持和加强市场轨迹。

市场动态：快速发展的Cystatin C检测法市场的关键市场洞察

Cystatin C检测法市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 肾臟疾病盛行率上升和老年人口不断增加
    • 肾臟病医疗基础建设投资进展
  • 市场限制因素
    • Cystatin C检测法开发成本高且发生产品召回
  • 市场机会
    • Cystatin C检测法测试的进展
    • 开始研究采用Cystatin C检测法来取代基于肌酸酐的测试
  • 市场挑战
    • 缺乏熟练的测试专业人员以及与Cystatin C检测法相关的技术挑战

波特五力：驾驭Cystatin C检测法市场的策略工具

波特五力架构是了解Cystatin C检测法市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Cystatin C检测法市场的外部影响

外部宏观环境因素在塑造Cystatin C检测法市场的动态动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解Cystatin C检测法市场的竞争状况

对Cystatin C检测法市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵Cystatin C检测法市场供应商的绩效评估

FPNV 定位矩阵是评估Cystatin C检测法市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分了供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肾臟疾病盛行率上升和老年人口增加
      • 积极投资肾臟疾病医疗基础设施
    • 抑制因素
      • Cystatin C检测的开发成本高且产品召回率高
    • 机会
      • Cystatin C检测法的进展
      • 新研究采用Cystatin C测试取代基于肌酸酐的测试
    • 任务
      • 缺乏熟练的实验室专业人员以及与Cystatin C检测法相关的技术挑战
  • 市场区隔分析
    • 产品：消费者首选的Cystatin C分析仪，用于诊断和状态监测
    • 方法：扩大酵素结合免疫吸附检测法(ELISA) 在Cystatin C测定中的应用
    • 背景：扩大Cystatin C检测在照护现场环境中的使用
    • 样本类型：尿液样本，Cystatin C检测法的关键作用是测量样本中肌酸酐的含量
    • 应用：扩大Cystatin C测定在肾功能诊断的应用
    • 最终用户：扩大Cystatin C测定在学术研究中心的生物标记研究中的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Cystatin C检测法市场：副产品

  • 分析仪
  • 套件
  • 试剂

第七章Cystatin C检测法市场：依方法分类

  • 化学冷光免疫检测
  • 酵素免疫分析法
  • 萤光测定
  • 颗粒增强免疫检测
  • 颗粒增强免疫检测

第 8 章Cystatin C检测法市场（依样本类型）

  • 血
  • 尿

第 9 章Cystatin C检测法市场设置

  • 实验室设置
  • 照护现场设置

第 10 章Cystatin C检测法市场：依应用分类

  • 使用诊断
  • 研究与开发

第 11 章 胱抑素Cystatin C检测法市场：依最终用户分类

  • 学术研究中心
  • 诊断实验室
  • 医院/诊所

第十二章 美洲Cystatin C检测法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太胱Cystatin C检测法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第14章 欧洲、中东和非洲的Cystatin C检测法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Jana Care 融资 600 万美元用于自我验血商业化
    • RhodesMed 宣布在马哈拉斯特拉邦开设第一个病理中心
    • Renalyse 完成 100 万欧元资金筹措，GENESIS Ventures 参与
    • Renalytix 选择 EVERSANA 扩大 KidneyIntelX 的商业化，用于 2 型糖尿病患者肾臟疾病的早期预后检测
    • 欧洲新的 eGFRCystatin C公式可能更准确
    • Jana Care 与罗氏合作开发和分销血液检测平台，以改善慢性肾臟病和心臟病患者的远距护理
    • Gentian Diagnostics ASA 签署Cystatin C经销协议
    • Bloom Diagnostics 宣布新的肾臟测试

公司名单

  • Abbexa Limited
  • Abbott Laboratories
  • Abcam PLC
  • Advy Chemical Pvt. Ltd.
  • Agilent Technologies, Inc.
  • AOBIOUS Inc.
  • Arbor Assays Inc.
  • Aviva Systems Biology Corporation
  • BBI Solutions OEM Limited
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biorbyt Ltd
  • BioVendor-Laboratorni medicina as
  • Boditech Med Inc.
  • Cepham Life Sciences, Inc.
  • Cusabio Technology LLC
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc. by General Atomics
  • Eagle Biosciences, Inc.
  • Elabscience Biotechnology Inc.
  • Ethos Biosciences, Inc.
  • Eurolyser Diagnostica GmbH by Mars, Incorporated
  • F. Hoffmann-La Roche Ltd
  • Fapon Biotech Inc.
  • Fortress Diagnostics Ltd.
  • Gentian Diagnostics ASA
  • Getein Biotech, Inc.
  • ImmunoDiagnostics Limited
  • Kamiya Biomedical Company
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Proteintech Group, Inc.
  • PZ CORMAY SA
  • Randox Laboratories Ltd.
  • RayBiotech, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Weldon Biotech
  • Zhejiang Kangte Biotechnology Co., Ltd.
Product Code: MRR-2E76C3E47F4F

The Cystatin C Assay Market was valued at USD 427.47 million in 2023, expected to reach USD 459.83 million in 2024, and is projected to grow at a CAGR of 7.24%, to USD 697.41 million by 2030.

A Cystatin C Assay is a medical diagnostic tool used to measure levels of cystatin C, a protein that reflects kidney function, providing a more accurate assessment than traditional creatinine tests. The necessity of this assay lies in its ability to offer earlier and precise information about declining renal function, making it essential in applications such as chronic kidney disease (CKD) monitoring, cardiovascular risk assessment, and research in nephrology. The end-use scope encompasses hospitals, diagnostic laboratories, and research institutes. The market is primarily driven by the rising prevalence of CKD, an aging population, and increasing demand for accurate diagnostics. Key influencing growth factors include advancements in assay technologies, heightened awareness about kidney health, and the integration of cystatin C testing within routine health check-ups. Latest opportunities are seen in emerging markets where healthcare infrastructure is improving and in regions witnessing a higher incidence of CKD due to lifestyle factors. Additionally, the development of combination assays that integrate genetic markers and cystatin C could tap into personalized medicine trends.

KEY MARKET STATISTICS
Base Year [2023] USD 427.47 million
Estimated Year [2024] USD 459.83 million
Forecast Year [2030] USD 697.41 million
CAGR (%) 7.24%

However, challenges like high costs, lack of awareness among medical professionals in developing regions, and variability in assay results due to non-standardized testing methods can impede market growth. Innovations are necessary in areas such as cost reduction through technological advances and enhancement of assay speed and accuracy. Investing in education and training for healthcare providers in emerging markets could better identify and promote the assay's benefits, broadening its adoption. The market is currently competitive and fragmented, driven by constant innovation and regulatory challenges, but opportunities for expansion exist through collaborations with biotech firms and focus on portable or point-of-care testing solutions. Overall, expanding applications in early diagnosis and chronic disease management will sustain and enhance market trajectory.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystatin C Assay Market

The Cystatin C Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of kidney diseases and growing geriatric population
    • Progressive investments in healthcare infrastructures for renal disorders
  • Market Restraints
    • High development costs of cystatin C assays and incidences of product recalls
  • Market Opportunities
    • Advances in cystatin C assay testing
    • Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
  • Market Challenges
    • Dearth of skilled lab professionals and technical challenges associated with cystatin C assay

Porter's Five Forces: A Strategic Tool for Navigating the Cystatin C Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystatin C Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystatin C Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystatin C Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystatin C Assay Market

A detailed market share analysis in the Cystatin C Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystatin C Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystatin C Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzer, Kits, and Reagents.
  • Based on Method, market is studied across Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay, Particle-enhanced Nephelometric Immunoassay, and Particle-enhanced Turbidimetric Immunoassay.
  • Based on Sample Type, market is studied across Blood and Urine.
  • Based on Setting, market is studied across Laboratory Setting and Point of Care Setting.
  • Based on Application, market is studied across Diagnosis Use and Research & Development.
  • Based on End-user, market is studied across Academic Research Centers, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
      • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in cystatin C assay testing
      • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
    • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
    • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
    • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
    • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
    • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystatin C Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Kits
  • 6.4. Reagents

7. Cystatin C Assay Market, by Method

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme linked Immunosorbent Assay
  • 7.4. Immunofluorescence Assay
  • 7.5. Particle-enhanced Nephelometric Immunoassay
  • 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Urine

9. Cystatin C Assay Market, by Setting

  • 9.1. Introduction
  • 9.2. Laboratory Setting
  • 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnosis Use
  • 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

  • 11.1. Introduction
  • 11.2. Academic Research Centers
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
    • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
    • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
    • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
    • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
    • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
    • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
    • 15.3.8. Bloom Diagnostics Launches New Kidney Test

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abbott Laboratories
  • 3. Abcam PLC
  • 4. Advy Chemical Pvt. Ltd.
  • 5. Agilent Technologies, Inc.
  • 6. AOBIOUS Inc.
  • 7. Arbor Assays Inc.
  • 8. Aviva Systems Biology Corporation
  • 9. BBI Solutions OEM Limited
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Bio-Techne Corporation
  • 12. Biorbyt Ltd
  • 13. BioVendor - Laboratorni medicina a.s.
  • 14. Boditech Med Inc.
  • 15. Cepham Life Sciences, Inc.
  • 16. Cusabio Technology LLC
  • 17. DIALAB GmbH
  • 18. DiaSys Diagnostic Systems GmbH
  • 19. Diazyme Laboratories, Inc. by General Atomics
  • 20. Eagle Biosciences, Inc.
  • 21. Elabscience Biotechnology Inc.
  • 22. Ethos Biosciences, Inc.
  • 23. Eurolyser Diagnostica GmbH by Mars, Incorporated
  • 24. F. Hoffmann-La Roche Ltd
  • 25. Fapon Biotech Inc.
  • 26. Fortress Diagnostics Ltd.
  • 27. Gentian Diagnostics ASA
  • 28. Getein Biotech, Inc.
  • 29. ImmunoDiagnostics Limited
  • 30. Kamiya Biomedical Company
  • 31. Laboratory Corporation of America Holdings
  • 32. Merck KGaA
  • 33. Proteintech Group, Inc.
  • 34. PZ CORMAY S.A.
  • 35. Randox Laboratories Ltd.
  • 36. RayBiotech, Inc.
  • 37. Sekisui Diagnostics, LLC
  • 38. Siemens Healthineers AG
  • 39. Sino Biological, Inc.
  • 40. Thermo Fisher Scientific Inc.
  • 41. Tosoh Corporation
  • 42. Weldon Biotech
  • 43. Zhejiang Kangte Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 26. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. CYSTATIN C ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 31. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 37. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 38. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 43. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 44. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 49. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 50. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 55. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 56. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 61. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 62. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 68. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 69. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 75. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 76. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 82. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 87. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 88. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 99. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 100. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 106. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 111. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 112. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 117. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 118. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 123. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 124. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 129. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 130. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 135. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 136. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 141. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 142. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 154. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 155. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 160. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 161. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 166. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 167. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 172. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 173. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 178. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 179. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 184. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 185. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 190. ITALY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 191. ITALY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 196. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 197. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 202. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 203. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 208. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 209. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 214. POLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 215. POLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 220. QATAR CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 221. QATAR CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 226. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 227. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 232. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 233. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 238. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 239. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 244. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 245. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 250. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 251. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 262. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 263. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 268. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 269. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 280. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023